Akums Drugs Announces Resignation of Senior Finance Executive
Filing Summary
Akums Drugs and Pharmaceuticals Ltd has announced the resignation of Mr. Rajkumar Bafna, President – Finance, effective December 31, 2025. This update was communicated to the National Stock Exchange of India and BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. Bafna’s resignation is due to personal reasons. The company has accepted his resignation and will relieve him of his duties on the specified date. Further details are provided in Annexure-A of the filing.
Akums Drugs and Pharmaceuticals Ltd has informed the National Stock Exchange of India and BSE Limited about the resignation of Mr. Rajkumar Bafna, who holds the position of President – Finance. The resignation is effective from December 31, 2025. This announcement was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Mr. Bafna, designated as Senior Management Personnel, has resigned due to personal reasons. The company has accepted his resignation and will relieve him from his duties on December 31, 2025. The details required under the SEBI regulations are provided in Annexure-A of the filing.
The filing specifies that Mr. Bafna’s resignation is categorized under cessation, and the effective date of his resignation is December 31, 2025. There is no additional information regarding a new appointment or re-appointment, as the filing does not pertain to such changes.
Akums Drugs and Pharmaceuticals Ltd is a company engaged in the manufacturing and marketing of pharmaceutical products. The company focuses on expanding its product portfolio and enhancing its manufacturing capabilities to meet the growing demand in the pharmaceutical sector.